Skip to main content
. 2020 Oct 19;2020(10):CD012859. doi: 10.1002/14651858.CD012859.pub2

KCT0000336.

Methods Randomized controlled trial
Participants Patients undergoing elective pelviscopic gynaecological surgery or breast operation, 19 to 65 years of age, ASA I and II, female
Interventions Palonosetron (0.075 mg) before end of surgery or ondansetron (8 mg) before end of surgery
Outcomes Nausea, retching, vomiting, complete response, pain
Notes Study status (recruiting), first posted (2012), missing information (anaesthesia regimen)